نتایج جستجو برای: facit

تعداد نتایج: 404  

2018
Mark Genovese Rene Westhovens Luc Meuleners Annegret Van der Aa Pille Harrison Chantal Tasset Arthur Kavanaugh

BACKGROUND The aim was to assess patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) treated with filgotinib during two phase 2b, 24-week, randomized, placebo-controlled studies. METHODS Patients with moderate-to-severe active RA and an inadequate response to methotrexate (MTX) were randomized to daily placebo or filgotinib 50 mg, 100 mg, or 200 mg as add-on therapy to...

2011
VIBEKE STRAND ANNE M. RENTZ MARY A. CIFALDI NAIJUN CHEN SANJOY ROY DENNIS REVICKI

Objective. Rheumatoid arthritis (RA) is associated with significant impairments in health-related quality of life (HRQOL). We evaluated patient-reported outcomes including HRQOL outcomes following adalimumab plus methotrexate (MTX) therapy in patients with early RA. Methods. PREMIER was a phase III, multicenter, randomized, double-blind, active-comparator clinical trial in early RA. Patients ag...

2017
Melody Swen Amandeep Mann Raheem J. Paxton Lorraine T. Dean

INTRODUCTION Cancer-related fatigue (CRF) is the most uncomfortable symptom among women with a history of breast cancer. Black women are more likely than women of other racial/ethnic groups to have CRF risk factors, such as physical inactivity and obesity, yet CRF studies have not focused on black women. We conducted a cross-sectional analysis to assess CRF and physical activity among black wom...

2014
Vibeke Strand Roger A Levy Ricard Cervera Michelle A Petri Helen Birch William W Freimuth Z John Zhong Ann E Clarke

OBJECTIVE Assess the effects of belimumab treatment plus standard systemic lupus erythematosus (SLE) therapy on health-related quality of life (HRQOL) in patients with active, autoantibody-positive SLE. METHODS Patients received standard therapy plus placebo or belimumab 1 or 10 mg/kg in two multicentre, randomised controlled trials of 52 (BLISS-52; N=865) and 76 (BLISS-76; N=819) weeks' dura...

2016
Samantha M. Bitter Patricia Heffron-Cartwright Christopher Wennerstrom Jared Weatherford Douglas Einstein Louis C. Keiler

PURPOSE To determine differences in patient's reported quality of life and self-reported breast cosmesis between whole breast radiation therapy (WBRT) and accelerated partial breast irradiation (APBI) via single and multi-lumen high-dose-rate (HDR) brachytherapy for women with early stage breast cancer. MATERIAL AND METHODS Patient information was retrospectively reviewed and survey data were...

2017
James A Chiarotto Riyad Akbarali Lara Bellotti George Dranitsaris

INTRODUCTION Exercise can improve the symptoms of cancer. However, is it a cancer treatment? We tested the feasibility of group exercise for metastatic cancer patients while on chemotherapy. A biomarker for exercise efficacy in colorectal cancer (CRC), β-catenin, was tested. METHODS Patients undergoing palliative chemotherapy were eligible for a pre-post, single-arm study comprising an indefi...

2017
Domenico Paolo Emanuele Margiotta Fabio Basta Giulio Dolcini Veronica Batani Marina Lo Vullo Alessia Vernuccio Luca Navarini Antonella Afeltra

INTRODUCTION The aim of this study was to evaluate the proportion of patients with Systemic Lupus Erythematosus (SLE) who did not met the WHO recommendations for physical activity and to evaluate the amount of time spent in sedentary behavior. METHODS SLE patients were consecutively enrolled in a cross sectional study. The type and the time spent in physical activity and sedentary behavior we...

2018
Carlo Buonerba Pietro De Placido Dario Bruzzese Martina Pagliuca Paola Ungaro Davide Bosso Dario Ribera Simona Iaccarino Luca Scafuri Antonietta Liotti Valeria Romeo Michela Izzo Francesco Perri Beniamino Casale Giuseppe Grimaldi Francesca Vitrone Arturo Brunetti Daniela Terracciano Alfredo Marinelli Sabino De Placido Giuseppe Di Lorenzo

Sunitinib is the most commonly prescribed drug for advanced renal cell carcinoma in the first-line setting and has been associated with multiple adverse events related to its on-and off-target effects, including hand and foot syndrome and fatigue. It was hypothesized that sunitinib-induced fatigue may be related to off target inhibition of the AMPK enzyme, which results in impairment of energy-...

Journal: :Arthritis and rheumatism 2008
E Keystone G R Burmester R Furie J E Loveless P Emery J Kremer P P Tak M S Broder E Yu M Cravets F Magrini F Jost

OBJECTIVE To assess the effects of treatment with rituximab plus methotrexate on patient-reported outcomes in patients with active rheumatoid arthritis (RA) who experienced inadequate response to anti-tumor necrosis factor therapy. METHODS Patients with active RA were randomly assigned to rituximab (1,000 mg on days 1 and 15) or placebo. The primary end point was the proportion of patients wi...

Journal: :Palliative & supportive care 2004
Karen E Steinhauser Elizabeth C Clipp Hayden B Bosworth Maya McNeilly Nicholas A Christakis Corrine I Voils James A Tulsky

OBJECTIVES To validate the QUAL-E, a new measure of quality of life at the end of life. METHODS We conducted a cross-sectional study to assess the instrument's psychometric properties, including the QUAL-E's associations with existing measures, evaluation of robustness across diverse sample groups, and stability over time. The study was conducted at the VA and Duke University Medical Centers,...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید